Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

This dose escalation study was designed to determine the maximum tolerated dose (MTD) and recommended doses (RDs) of 5-fluorouracil (5FU), folinic acid and oxaliplatin (FOLFOX) with concomitant radiotherapy in inoperable/metastatic oesophageal squamous cell carcinoma or adenocarcinoma. Patients rece...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Conroy, T, Viret, F, François, E, Seitz, J F, Boige, V, Ducreux, M, Ychou, M, Metges, J P, Giovannini, M, Yataghene, Y, Peiffert, D
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2008
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2579679/
https://ncbi.nlm.nih.gov/pubmed/18841161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604708
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars